MORACE, Carmela
 Distribuzione geografica
Continente #
EU - Europa 3.078
NA - Nord America 2.919
AS - Asia 1.617
SA - Sud America 465
Continente sconosciuto - Info sul continente non disponibili 138
AF - Africa 50
OC - Oceania 2
Totale 8.269
Nazione #
US - Stati Uniti d'America 2.818
RU - Federazione Russa 1.699
SG - Singapore 595
CN - Cina 476
BR - Brasile 382
IE - Irlanda 325
SE - Svezia 282
IT - Italia 234
HK - Hong Kong 201
DE - Germania 134
VN - Vietnam 119
FR - Francia 85
FI - Finlandia 81
GB - Regno Unito 63
IN - India 63
CA - Canada 41
PL - Polonia 39
UA - Ucraina 28
AR - Argentina 26
BD - Bangladesh 26
MX - Messico 22
EE - Estonia 21
BE - Belgio 18
TR - Turchia 18
VE - Venezuela 15
AT - Austria 14
ES - Italia 14
ID - Indonesia 14
IQ - Iraq 14
PK - Pakistan 13
EC - Ecuador 12
NL - Olanda 12
CO - Colombia 11
MA - Marocco 11
MY - Malesia 10
UZ - Uzbekistan 10
ZA - Sudafrica 9
AE - Emirati Arabi Uniti 8
CI - Costa d'Avorio 8
CR - Costa Rica 8
CZ - Repubblica Ceca 8
JP - Giappone 8
JM - Giamaica 7
KE - Kenya 7
LT - Lituania 7
PH - Filippine 7
NP - Nepal 6
TT - Trinidad e Tobago 6
CL - Cile 5
KG - Kirghizistan 5
PT - Portogallo 5
TN - Tunisia 5
EG - Egitto 4
IL - Israele 4
NI - Nicaragua 4
PE - Perù 4
SA - Arabia Saudita 4
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
GT - Guatemala 3
HN - Honduras 3
JO - Giordania 3
KZ - Kazakistan 3
PY - Paraguay 3
UY - Uruguay 3
BB - Barbados 2
DK - Danimarca 2
HU - Ungheria 2
SV - El Salvador 2
TG - Togo 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
HT - Haiti 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PG - Papua Nuova Guinea 1
QA - Qatar 1
SC - Seychelles 1
SR - Suriname 1
TH - Thailandia 1
TM - Turkmenistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.135
Città #
Moscow 474
Ashburn 462
Singapore 341
Dublin 325
Dallas 240
San Jose 208
Chandler 205
Hong Kong 200
Beijing 148
Nyköping 134
Jacksonville 85
The Dalles 84
Council Bluffs 77
Los Angeles 72
Messina 62
Munich 56
Ann Arbor 52
Medford 43
Princeton 43
New York 41
Lauterbourg 39
Ho Chi Minh City 38
Cambridge 36
Dearborn 36
Des Moines 35
Santa Clara 35
Warsaw 34
São Paulo 31
Hanoi 28
Buffalo 22
Turku 22
Pune 21
Boardman 20
Nuremberg 20
Brooklyn 19
Catania 19
Chennai 19
Tianjin 18
Brussels 17
Chicago 16
Helsinki 14
North Bergen 14
Guangzhou 13
Lancaster 13
Montreal 13
Woodbridge 13
Brasília 12
Bremen 12
Frankfurt am Main 12
Orem 12
Redondo Beach 12
Salerno 12
Atlanta 11
Haikou 11
Houston 11
Phoenix 11
Stockholm 11
Rio de Janeiro 10
Shanghai 10
Shenyang 10
Bari 9
Jinan 9
Mexico City 9
San Francisco 9
Tashkent 9
Abidjan 8
Amsterdam 8
Denver 8
Düsseldorf 8
Jakarta 8
San Mateo 8
Shenzhen 8
Vienna 8
Belo Horizonte 7
Hyderabad 7
Nanjing 7
Tokyo 7
Washington 7
Columbus 6
Espoo 6
Haiphong 6
Johannesburg 6
Kuala Lumpur 6
Manchester 6
Miami 6
Nairobi 6
Palermo 6
Rome 6
Salvador 6
San José 6
Scandicci 6
Seattle 6
Zhengzhou 6
Bishkek 5
Brno 5
Casablanca 5
Curitiba 5
Feira de Santana 5
Istanbul 5
Lahore 5
Totale 4.383
Nome #
CD34+ cell count predicts long lasting life in the oldest old. 323
Abnormal left ventricular global strain during exercise-test in young healthy smokers 284
Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. 255
A comparison of uncovered metal stents for the palliation of patients withmalignant biliary obstruction: nitinol vs. stainless steel 225
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma 211
Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects. 210
Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma? 207
High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder. 204
Expression and change of mirs 145, 221 and 222 in hypertensive subjects treated with enalapril, losartan or olmesartan 188
Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review 184
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 182
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 178
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 172
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. 170
The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus 157
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 157
Carbon dioxide insufflation versus air insufflation during endoscopic retrograde cholangiopancreatography under general anesthesia. 156
High circulating D-dimers are associated with ascites and hepatocellularcarcinoma in liver cirrhosis. 155
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy 154
Endocan and circulating progenitor cells in women with systemic sclerosis: Association with inflammation and pulmonary hypertension 150
Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study. 147
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units 143
High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. 136
Complications of endoscopic ultrasonography. 135
Current practice of hepatitis C treatment in Southern Italy. 133
Endoscopic resection as a safe and effective technique for treatment of pedunculated and non-pedunculated benign-appearing colorectal neoplasms measuring 40 mm or more in size 131
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs? 131
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. 131
Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients 127
Endoscopic management of bile duct injury after hepatobiliary tract surgery: a comprehensive review. 127
Endoscopic tattooing of gastrointestinal and pancreatic lesions. 124
Pancreatic necrosectomy: an evidence-based systematic review of the levels of evidence and a comparison of endoscopic versus non-endoscopic techniques. 124
Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review 124
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 120
Current practice of chronic hepatitis B treatment in Southern Italy. 119
Cholangioscopy using a new type of cholangioscope for the diagnosis of biliary tract disease: a case series. 114
On the efficacy of penicillins for Helicobacter pylori eradication 113
Unlocking the Predictive Power of Nutritional Scores in Septic Patients 110
Short- and long-term outcomes of self-expanding metal stent placement as a bridgeto surgery for acute left-sided colorectal cancer obstruction 107
Through-the-scope large diameter self-expanding metal stent placement as a safe and effective technique for palliation of malignant colorectal obstruction: a single center experience with a long-term follow-up 98
Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease 95
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Calcium Homeostasis: Where We Stand Now 93
High Serum Resistin in Chronic Viral Hepatitis Is not a Marker of Metabolic Disorder 92
GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia. 91
Liver steatosis in celiac disease: the open door. 90
Molecular findings on Helicobacter pylori: update for clinicians. 88
Endoscopic marking methods 87
Is Helicobacter pylori the infectious target to prevent gastric cancer? An interdisciplinary point of view. 86
Expanding the Use of SGLT2 Inhibitors in T2D Patients Across Clinical Settings 85
Placement of a new fully covered self-expanding metal stent for postoperative biliary strictures and leaks not responding to plastic stenting. 85
Retrospective Analysis of Fever in Pediatric Age: Our Experience over the Last 5 Years 84
null 81
Current practice of hepatitis C treatment in Southern Italy. 80
Is pregnancy a predisposing factor for Dieulafoy's duodenal lesion or only a coincidence? 80
Minerva Gastroenterol Dietol 79
THE MULTIPLE EFFECTS OF VITAMIN D ON CHRONIC DISEASES 75
Impact of Coronavirus Disease 2019 Lockdown on Quality of Life and Locus of Control in Elderly Subjects with Type 2 Diabetes 73
Ketoacidosis and SGLT2 Inhibitors: A Narrative Review 72
null 67
Through-the-scope large diameter self-expanding metal stent placement as a safeand effective technique for palliation of malignant colorectal obstruction: asingle center experience with a long-term follow-up 60
null 52
Cardiovascular Risk Assessments and Ultrasound-Assisted Re-Stratification in Patients with Inflammatory Bowel Disease (IBD) 50
null 39
null 27
null 24
Trabecular bone score enhances fracture risk stratification in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus 18
Totale 8.269
Categoria #
all - tutte 28.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022275 0 0 0 9 10 0 17 7 2 82 49 99
2022/2023838 59 98 37 53 52 68 8 57 372 4 23 7
2023/2024308 11 33 21 39 23 68 3 20 7 24 29 30
2024/20251.356 17 27 12 102 63 70 47 191 297 127 129 274
2025/20264.037 253 231 281 278 343 763 464 530 525 203 65 101
2026/2027773 76 237 186 274 0 0 0 0 0 0 0 0
Totale 8.269